Clinical Trials on Recurrent Pregnancy Losses

Total 64201 results

National Cancer Institute (NCI)
NRG Oncology

Completed

Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
National Cancer Institute (NCI)
NRG Oncology

Completed

Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
University of Wisconsin, Madison
National Institutes of Health (NIH)

Completed

Vaccine for Recurrent Urinary Tract Infections in Women

Recurrent Urinary Tract Infections in Women

United States
Al-Azhar University

Not yet recruiting

Uterine Artery Doppler Changes After Vaginal Administration of Isosorbide Mononitrate In Patients With URPL

Recurrent Pregnancy Loss
Leiden University Medical Center

Not yet recruiting

On Pregnancy After Losses - OPAL Study (OPAL)

Recurrent Pregnancy Loss
Yazd Medical University

Completed

Effectiveness of Aspirin in Compare With Heparin Plus Aspirin in Recurrent Pregnancy Loss Treatment

Recurrent Pregnancy Loss

Iran, Islamic Republic of
Universitaire Ziekenhuizen KU Leuven

Recruiting

Preimplantation Genetic Testing for Aneuploidies in Patients With Recurrent Implantation Failure

Recurrent Implantation Failure

Belgium
Novartis Pharmaceuticals

Completed

Safety and Tolerability of ASA404 Administered in Combination With Docetaxel in Japanese Patients With Solid Tumors

Advanced or Recurrent Solid Tumors

Japan
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Adavosertib With or Without Olaparib in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
Northwestern University
National Cancer Institute (NCI); Merck Sharp & Dohme LLC; Astex Pharmaceuticals...

Completed

Guadecitabine and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Terminated

Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Withdrawn

PD 0360324 and Cyclophosphamide in Treating Patients With Recurrent High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Rilotumumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

A Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
Women's Hospital School Of Medicine Zhejiang University

Recruiting

Establishment of Special Disease Cohort for RPLand Study of Impact Mechanism of Early Embryo Development

Recurrent Pregnancy Loss

China
Rigshospitalet, Denmark

Recruiting

Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss

Recurrent Pregnancy Loss

Denmark
Johns Hopkins University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...

Enrolling by invitation

Preventing Recurrent UTI With Vaginal Estrogen (PRUVE)

Urinary Tract Infections | Recurrent Urinary Tract Infection | Cystitis Recurrent

United States
BioGaia AB

Completed

Double-blinded, Randomized, Placebo-controlled Study Evaluating the Effect of the Probiotic on Recurrent Urinary Tract Infection

Recurrent Urinary Tract Infection in Adult Women

Sweden
Lawson Health Research Institute
Ontario Institute for Cancer Research

Completed

Advanced Prostate Imaging of Recurrent Cancer After Radiotherapy (PICs)

Prostate Cancer

Canada
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Active, not recruiting

Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
National Cancer Institute (NCI)

Completed

Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
National Cancer Institute (NCI)
NRG Oncology

Completed

Bevacizumab With or Without Fosbretabulin Tromethamine in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Stereotactic Body Radiation Therapy or Intensity Modulated Radiation/Proton Therapy in Treating Patients With Recurrent Head and Neck Cancer

Recurrent Head and Neck Carcinoma

United States
Institute For Advanced Reconstruction

Unknown

Review of Complex Recurrent Hernia Repair (BARS)

Recurrent Hernia

United States
Lawson Health Research Institute
University of Western Ontario, Canada

Completed

Effects of Antibiotic Prophylaxis on Recurrent UTI in Children

Urinary Tract Infection | Recurrent Urinary Tract Infection

Canada
University of Thessaly

Unknown

Prophylactic Use of Cranberries in Recurrent Bacterial Cystitis in Women

Recurrent Urinary Tract Infections in Women
Mansoura University Hospital

Completed

Hysteroscopic Septoplasty by Different Modalities

Recurrent Pregnancy Loss | Subfertility | Septate Uterus

Egypt
National Cancer Institute (NCI)

Completed

A Phase II Study of Akt Inhibitor MK2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Sarcoma

United States
Southwest Hospital, China

Unknown

A Study of Laparoscopic Hepatectomy Versus RFA in the Treatment of Recurrent HCC

Hepatocellular Carcinoma Recurrent

China
University Hospitals of Derby and Burton NHS Foundation...

Not yet recruiting

3D Ultrasound to Assess in Recurrent Miscarriage (3D-ARM)

Recurrent Miscarriage
Jianmei Xia

Completed

Study on Clinical Value of Vitamin D in Recurrent Spontaneous Abortion

Vitamin D Deficiency | Recurrent Spontaneous Abortion

China
Jonsson Comprehensive Cancer Center
Merck Sharp & Dohme LLC

Active, not recruiting

Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
Memorial Sloan Kettering Cancer Center

Completed

Image-Guided Navigation for High Dose Rate Temporary Interstitial Brachytherapy in the Palliative Management of Previously Treated Tumors of the Spine and Pelvis

Metastatic or Recurrent Lesions in the Spine | Metastatic or Recurrent Lesions in the Pelvis

United States
PharmaMatrix Holdings Ltd
University of Alberta

Recruiting

A Study of CCI-001 in Patients With Recurrent and/or Metastatic Solid Tumours

Cancer: Recurrent and/or Metastatic Solid Tumours

Canada
Sun Yat-sen University

Unknown

Conjunctival Autograft or Limbal Conjunctival Autograft for Recurrent Pterygium Using Mitomycin C

Recurrent Pterygium

China
Instituto de Oftalmología Fundación Conde de Valenciana
National Council of Science and Technology, Mexico

Completed

Bevacizumab Injection for Recurrent Pterygium

Recurrent Pterygium

Mexico
Shiyou Zhou

Completed

Recurrent Pterygium Surgery Using Mitomycin C With Limbal Conjunctival or Amniotic Membrane

Recurrent Pterygium

China
Instituto de Olhos de Goiania

Completed

Subconjunctival Bevacizumab and Recurrent Pterygium (BRP)

Recurrent Pterygium

Brazil
National Taiwan University Hospital

Completed

Evaluation of the Treatment of Recurrent Corneal Erosions by Anterior Stromal Puncture With Nd: YAG Laser

Trauma | Recurrent Corneal Erosion

Taiwan
Federal University of São Paulo

Unknown

Amniotic Membrane Associated With Conjunctival Autograft Versus Conjunctival Autograft for Recurrent Pterygia

Recurrent Pterygia
AGO Research GmbH

Recruiting

Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer (MIROVA)

Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma

Germany
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer

Cervical Squamous Cell Carcinoma | Recurrent Cervical Carcinoma

United States
Emory University
National Cancer Institute (NCI); Blue Earth Diagnostics

Active, not recruiting

Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer

Prostate Adenocarcinoma | Recurrent Prostate Carcinoma

United States
Beijng Immunoah Pharma Tech Co., Ltd.

Recruiting

Safety/Tolerability, PK and Efficacy of IMB071703 Injection in Patients With Advanced Solid Tumors

Recurrent or Metastatic, Advanced Solid Tumors

China
Centre for Endocrinology and Reproductive Medicine...

Recruiting

Use of GM-CSF Treatment in Recurrent Implantation Failure

Women With Recurrent Implantation Failure in IVF

Italy
Sidney Kimmel Comprehensive Cancer Center at Johns...

Withdrawn

TA-CIN Vaccine With Anti-PD-1 Therapy in Recurrent HPV16-associated Cancers

Recurrent Human Papillomavirus Type 16 Associated Cancer

United States
University of Oslo
Göteborg University; UMC Utrecht; Medical University of Lodz; Amsterdam UMC, location...

Enrolling by invitation

The Effect of Methenamine Hippurate to Reduce Antibiotic Prescribing in Elderly Women With Recurrent UTI (ImpresUWP3)

Recurrent Urinary Tract Infection

Netherlands, Norway, Poland, Sweden
Memorial Sloan Kettering Cancer Center

No longer available

Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission Tomography

Recurrent Prostate Cancer | Prostate Cancer

United States
SonaCare Medical

Unknown

A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial) (STAR)

Recurrent Prostate Cancer

United States, Canada

Clinical Trials on Recurrent Pregnancy Losses

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations